Synopsys, Inc. (NASDAQ:SNPS – Get Free Report) has received an average rating of “Moderate Buy” from the thirteen research firms that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and twelve have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $618.31.
Several brokerages recently issued reports on SNPS. Mizuho reduced their price objective on shares of Synopsys from $650.00 to $600.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 15th. Piper Sandler decreased their price objective on Synopsys from $655.00 to $653.00 and set an “overweight” rating on the stock in a report on Thursday, February 27th. Wells Fargo & Company lowered their price objective on Synopsys from $540.00 to $520.00 and set an “equal weight” rating for the company in a research report on Thursday, February 27th. KeyCorp reduced their target price on Synopsys from $690.00 to $555.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 15th. Finally, Redburn Atlantic assumed coverage on Synopsys in a report on Monday, January 13th. They issued a “buy” rating and a $600.00 price target for the company.
View Our Latest Stock Report on Synopsys
Insider Activity
Hedge Funds Weigh In On Synopsys
A number of institutional investors have recently added to or reduced their stakes in SNPS. Norges Bank acquired a new position in shares of Synopsys in the fourth quarter worth about $583,608,000. GAMMA Investing LLC raised its position in shares of Synopsys by 54,286.0% in the 1st quarter. GAMMA Investing LLC now owns 1,196,492 shares of the semiconductor company’s stock valued at $513,116,000 after purchasing an additional 1,194,292 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its stake in shares of Synopsys by 21.5% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 5,902,696 shares of the semiconductor company’s stock valued at $2,864,933,000 after buying an additional 1,045,326 shares during the last quarter. Capital Research Global Investors acquired a new stake in shares of Synopsys during the fourth quarter worth approximately $239,864,000. Finally, Raymond James Financial Inc. bought a new stake in shares of Synopsys in the fourth quarter worth $199,065,000. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Stock Up 2.7 %
NASDAQ SNPS opened at $413.40 on Friday. Synopsys has a fifty-two week low of $365.74 and a fifty-two week high of $624.80. The business has a fifty day moving average of $441.91 and a 200-day moving average of $493.85. The stock has a market cap of $63.92 billion, a price-to-earnings ratio of 28.47, a price-to-earnings-growth ratio of 3.23 and a beta of 1.23.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- EV Stocks and How to Profit from Them
- How to Invest in Micro-Cap Stocks Like a Pro
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Investors Sell Microsoft Stock on OpenAI News—Time to Buy?
- What Are the U.K. Market Holidays? How to Invest and Trade
- Take-Two Interactive: A Defensive Play Set to Explode
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.